|
Q3 FY2018
As of Dec 31, 2017
|
Q2 FY2018
As of Sep 30, 2017
|
Q1 FY2018
As of Jun 30, 2017
|
Q4 FY2017
As of Mar 31, 2017
|
Q3 FY2017
As of Dec 31, 2016
|
Q2 FY2017
As of Sep 30, 2016
|
Q1 FY2017
As of Jun 30, 2016
|
Q4 FY2016
As of Mar 31, 2016
|
Q3 FY2016
As of Dec 31, 2015
|
Q2 FY2016
As of Sep 30, 2015
|
Q1 FY2016
As of Jun 30, 2015
|
Q4 FY2015
As of Mar 31, 2015
|
Q3 FY2015
As of Dec 31, 2014
|
Q2 FY2015
As of Sep 30, 2014
|
Q1 FY2015
As of Jun 30, 2014
|
Q4 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Cash and due from banks | ||||||||||||||||
| Interest-bearing deposits in other banks | ||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||
| Securities available for sale, at fair value | ||||||||||||||||
| Securities held to maturity, at cost (fair value of $268,957 at December 31, 2017 and $311,509 at March 31, 2017): | ||||||||||||||||
| Loans receivable | ||||||||||||||||
| Allowance for loan losses | ||||||||||||||||
| Net Loans | ||||||||||||||||
| Bank owned life insurance | ||||||||||||||||
| Premises and equipment | ||||||||||||||||
| Federal Home Loan Bank of New York stock | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Real estate owned | ||||||||||||||||
| Other assets | ||||||||||||||||
| Total Assets | ||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||
| Liabilities | ||||||||||||||||
| Deposits: | ||||||||||||||||
| Non-interest bearing | ||||||||||||||||
| Interest bearing | ||||||||||||||||
| Total Deposits | ||||||||||||||||
| Advances from Federal Home Loan Bank of New York | ||||||||||||||||
| Advance payments by borrowers for taxes and insurance | ||||||||||||||||
| Other liabilities and accrued expenses | ||||||||||||||||
| Total Liabilities | ||||||||||||||||
| Stockholders' Equity | ||||||||||||||||
| Preferred stock ($.01 par value), 10,000,000 shares authorized; none issued or outstanding | ||||||||||||||||
| Common stock ($.01 par value), 85,000,000 shares authorized; 22,099,814 issued and outstanding at December 31, 2017; 22,548,529 issued and outstanding at March 31, 2017 | ||||||||||||||||
| Paid-in capital | ||||||||||||||||
| Deferred compensation obligation under Rabbi Trust | ||||||||||||||||
| Retained earnings | ||||||||||||||||
| Common stock acquired by Employee Stock Ownership Plan ("ESOP") | ||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||
| Stock held by Rabbi Trust | ||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||
| Total Liabilities and Stockholders' Equity | ||||||||||||||||
Loading...
